Loading clinical trials...
Loading clinical trials...
Patients who were vaccinated with AFFITOPE AD01 during AFFiRiS001 will undergo a long-term follow-up period to get more information regarding the safety profile of AFFITOPE AD01.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Affiris AG
NCT06731842 · Alzheimer´s Disease
NCT02224326 · Alzheimer´s Disease
NCT02623764 · Alzheimer´s Disease
NCT00692705 · Alzheimer´s Disease
Univ. Klinik für Neurologie
Vienna
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions